Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults
This study has been terminated.
( Interim data indicated that subjects exhibited no meaningful allergic disease during the first ragweed season, making it impossible to measure treatment effect. )
Study NCT00387738   Information provided by Dynavax Technologies Corporation
First Received: October 11, 2006   Last Updated: January 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rhinitis, Allergic, Seasonal
Additional conditions recognized in this trial
Rhinitis
More general conditions related to this trial
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Histamine base
Sponsors listed in this trial
Dynavax Technologies Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services